William W. Burke - 11 Nov 2026 Form 4 Insider Report for Covista Inc. (CVSA)

Reporting relationship: Director
Issuer ticker: CVSA
Reported as of: 11 Nov 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Nov 2026, 16:22:41 UTC
Prior SEC filing: 09 Nov 2026
Next SEC filing: 13 Nov 2026
Source filing: View source filing
Reporting owner signature: /s/ Lawrence C. Bachman, attorney-in-fact for Mr. Burke

Filing notes and source

Key filing fact

William W. Burke filed Form 4 for Covista Inc. (CVSA) on 13 Nov 2026.

Key facts

This page summarizes William W. Burke's Form 4 filing for Covista Inc. (CVSA).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Nov 2026, 16:22.

Change

Previous filing in this sequence was filed on 09 Nov 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001200612 Primary reporting owner

BURKE WILLIAM W

Relationship: Director
Address: 233 S. WACKER DRIVE, SUITE 800, CHICAGO
Signature: /s/ Lawrence C. Bachman, attorney-in-fact for Mr. Burke
Signature date: 13 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVSA transaction

Common Stock

Award

Transaction value
Shares: +1,255
Change %: +12%
Price: $119.55^*
Shares after: 11,678
Date: 11 Nov 2026
Ownership: Direct
Footnotes: F1, F2

CVSA transaction

Common Stock

Tax liability

Transaction value
Shares: -362
Change %: -3.1%
Price: $119.00^*
Shares after: 11,316
Date: 12 Nov 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date.

Footnote F2

The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $119.55, the closing price of CVSA common stock on November 11, 2026.

Footnote F3

Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units.